IV Fluids in Acute Kidney Injury
Yes, you should give IV fluids to patients with AKI, but the approach depends critically on the patient's volume status and the cause of AKI—use isotonic crystalloids (preferably balanced solutions) for volume resuscitation in hypovolemic or at-risk patients, but restrict fluids in established AKI with volume overload or in patients unresponsive to fluid administration.
Initial Assessment and Fluid Strategy
The decision to administer IV fluids in AKI requires immediate assessment of:
- Volume status: Is the patient hypovolemic, euvolemic, or volume overloaded?
- Fluid responsiveness: Will additional fluid improve renal perfusion?
- AKI etiology: Is this prerenal (fluid-responsive) or established intrinsic AKI?
For Hypovolemic or At-Risk Patients
Use isotonic crystalloids as your first-line therapy 1. The KDIGO guideline specifically recommends isotonic crystalloids rather than colloids (albumin or starches) for initial intravascular volume expansion in patients at risk for or with AKI 1.
Prefer balanced crystalloids over normal saline 2, 3. Recent evidence increasingly supports balanced solutions because:
- Normal saline can cause hyperchloremic metabolic acidosis 4, 3
- Chloride-rich solutions impair renal blood flow through autoregulatory mechanisms 5
- Balanced solutions may reduce the risk of kidney injury 3
For Established AKI with Volume Overload
In patients with established AKI who are unresponsive to fluid administration, fluid restriction is the treatment of choice 3. This is critical because:
- Both hypovolemia AND volume overload are associated with increased morbidity and mortality 3
- Excess fluids cause kidney interstitial edema and venous congestion, preventing renal blood flow and glomerular filtration 5
- Positive fluid balance is significantly associated with stage 3 AKI and increased mortality 6
Monitoring Fluid Responsiveness
Use dynamic rather than static measures to assess fluid responsiveness 3:
- Dynamic indicators: Stroke volume variation, pulse pressure variation, passive leg-raising test, end-expiratory occlusion test
- Avoid relying solely on: Central venous pressure or pulmonary artery occlusion pressure (these static measures are less reliable) 3
Specific Fluid Choices to Avoid
Do not use hydroxyethyl starches (HES) 1. The 6S Trial showed that HES 130/0.42 resulted in:
- More deaths
- More patients requiring renal replacement therapy
- More severe bleeding episodes compared to Ringer's acetate 1
Avoid synthetic colloids (HES, gelatins, dextrans) as they are potentially nephrotoxic and can cause osmotic nephrosis, particularly in patients with reduced renal reserve 5.
Common Pitfalls
- Overzealous fluid resuscitation: Can worsen outcomes, particularly in established AKI or conditions like malaria-induced AKI where it may increase risk of acute lung injury 1
- Continuing fluids despite lack of response: If the patient doesn't respond to initial fluid therapy, switch to fluid restriction rather than continuing administration 3
- Using colloids when crystalloids suffice: Despite theoretical advantages, colloids show no mortality benefit and add unnecessary cost and potential harm 1
Optimal Timing Strategy
The best approach involves timely guided fluid resuscitation with appropriate solutions, followed by appropriate fluid balance management 3. This means:
- Early phase: Aggressive crystalloid resuscitation if hypovolemic
- Reassessment: Continuous monitoring of fluid responsiveness
- Transition: Switch to fluid restriction once euvolemia achieved or if unresponsive to fluids